A Better Overall Survival (OS) for Total (ipsilateral) Retroperitoneal Lipectomy Than Standard Complete Resection in Patients with Retroperitoneal Liposarcoma: a Comparative Multi-Institutional Study
Cheng-Li Miao,Ling-Ling Zhang,William W. Tseng,Fa-Bo Qiu,Wei-Qi Lu,You-Guo Dai,Xiao-Song Rao,Wen-Jie Li,Gao-Kui Zhang,Jun Chen,Wen-Qing Liu,Xiao-Bing Chen,Meng-Meng Xiao,Li-Chao Cha,Jiong-Yuan Wang,Yu-Bo Ren,Hao-Yun Yang,Cheng-Hua Luo
DOI: https://doi.org/10.21037/atm-22-3332
IF: 3.616
2022-01-01
Annals of Translational Medicine
Abstract:Background: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively compare the clinical outcomes of RPLS patients treated with total (ipsilateral) retroperitoneal lipectomy (TRL) and CR. Because TRL remove potentially multifocal tumors in the fat, patients may have a better prognosis than CR. Methods: Patients with primary/first-recurrent RPLS who had been treated at 5 referral centers were recruited from December 2014 to June 2018. Multivariable Cox regression analyses were conducted to determine the effects of demographic, operative, and clinicopathological variables on the following primary endpoints: local recurrence (LR), local recurrence-free survival (LRFS), and overall survival (OS). Results: A total of 134 patients were enrolled in this retrospective study, 53 of whom underwent TRL, and 81 of whom underwent CR. The 2 groups were comparable in terms of age, gender, presentation (primary vs. first-recurrent RPLS), number of tumors (unifocal vs. multifocal) at presentation, and Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade. The TRL group had higher levels of preoperative hemoglobin (Hb) (13 vs. 12.5 g/dL; P=0.008) and a lower amount of intraoperative blood loss (400 vs. 500 mL; P=0.034), but there were no significant differences in the length of hospital stay (23 vs. 22 d; P=0.47) or complications (32 vs. 30; P=0.82) between the 2 groups. In a subset of patients with multifocal tumors at initial presentation, OS was more prolonged in those treated with TRL than those treated with CR (P=0.0272). Based on the multivariable analysis, primary liposarcoma and a low FNCLCC grade were associated with decreased LR and improved OS. Conclusions: TRL is a safe procedure that positively affects the OS of patients with multifocal RPLS. This novel strategy deserves further investigation in prospective studies.